文献速递妇科

小分子抑制CBFβ/RUNX相互作用通过改变上皮-间质转化相关基因减少卵巢癌生长和迁移

Small molecule inhibition of the CBFβ/RUNX interaction decreases ovarian cancer growth and migration through alterations in genes related to epithelial-to-mesenchymal transition.
PubMed 文献 · Gynecol Oncol · 2018-03-16

本研究在卵巢癌细胞系中检测化学抑制CBFβ/RUNX蛋白相互作用的效果。抑制剂降低细胞增殖、导致S期延迟和DNA复制减慢,并减少伤口愈合和锚定非依赖性生长;RNA-Seq显示增殖和上皮-间质转化相关基因表达改变,敲低INHBA和MMP1可减慢DNA复制并损害伤口愈合。作者认为化学抑制CBFβ/RUNX相互作用是治疗卵巢癌的可行策略。

要点

  • CBFβ/RUNX抑制剂降低卵巢癌细胞增殖并导致S期细胞周期延迟。
  • 抑制剂减少伤口愈合和锚定非依赖性生长,并改变上皮-间质转化相关基因表达。
  • 敲低INHBA和MMP1可减慢DNA复制并损害伤口愈合。

核心结论

  • 化学抑制CBFβ/RUNX相互作用是治疗卵巢癌的可行策略。

研究设计与样本

  • 研究在卵巢癌细胞系中进行,使用CBFβ/RUNX抑制剂处理细胞,检测增殖、DNA复制、伤口愈合和锚定非依赖性生长,并对化合物处理细胞进行RNA-Seq及siRNA靶向验证。

主要发现

  • 化学抑制CBFβ/RUNX相互作用降低卵巢癌细胞增殖。
  • 抑制剂处理导致S期细胞周期延迟,表现为S期细胞百分比增加和DNA复制速率降低。
  • 抑制剂处理减少伤口愈合和锚定非依赖性生长。
  • RNA-Seq显示少量与增殖和上皮-间质转化相关的基因表达改变。
  • siRNA介导敲低INHBA和MMP1(化合物处理后表达下降的两个基因)减慢DNA复制并损害伤口愈合。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Ovarian cancer survival and treatment have improved minimally in the past 20years. Novel treatment strategies are needed to combat this disease. This study investigates the effects of chemical inhibition of the CBFβ/RUNX protein-protein interaction on ovarian cancer cell lines. METHODS: Ovarian cancer cell lines were treated with CBFβ/RUNX inhibitors, and the effects on proliferation, DNA replication, wound healing, and anchorage-independent growth were measured. RNA-Seq was performed on compound-treated cells to identify differentially expressed genes. Genes altered by compound treatment were targeted with siRNAs, and effects on DNA replication and wound healing were measured. RESULTS: Chemical inhibition of the CBFβ/RUNX interaction decreases ovarian cancer cell proliferation. Inhibitor treatment leads to an S-phase cell cycle delay, as indicated by an increased percentage of cells in S-phase, and a decreased DNA replication rate. Inhibitor treatment also reduces wound healing and anchorage-independent growth. RNA-Seq on compound-treated cells revealed changes in a small number of genes related to proliferation and epithelial-to-mesenchymal transition. siRNA-mediated knockdown of INHBA and MMP1 - two genes whose expression decreases with compound treatment - slowed DNA replication and impaired wound healing. CONCLUSIONS: Chemical inhibition of the CBFβ/RUNX interaction is a viable strategy for the treatment of ovarian cancer.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Carlton AL, Illendula A, Gao Y, et al. Small molecule inhibition of the CBFβ/RUNX interaction decreases ovarian cancer growth and migration through alterations in genes related to epithelial-to-mesenchymal transition. Gynecol Oncol. 2018. PMID: 29551565. doi:10.1016/j.ygyno.2018.03.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。